List of insiders holdings for Prevail Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Tyto Acquisition Corp ELI LILLY & Co 10% Owner | 2021-01-22 16:26:04 | 100 0 | 100 | Form 4 |
| 2 | Thompson Peter A. Director 10% Owner | 2021-01-26 17:05:26 | 0 0 | 0 | Form 4 |
| 3 | GORDON CARL L Director 10% Owner | 2021-01-26 17:06:16 | 0 0 | 0 | Form 4 |
| 4 | Nussbaum Ran Director | 2021-01-26 17:07:13 | 0 0 | 0 | Form 4 |
| 5 | Sheng Morgan Director | 2021-01-26 17:08:05 | 0 0 | 0 | Form 4 |
| 6 | Sevigny Jeffrey Chief Medical Officer | 2021-01-26 17:09:56 | 0 0 | 0 | Form 4 |
| 7 | Schwartz Kira M. General Counsel | 2021-01-26 17:11:05 | 0 0 | 0 | Form 4 |
| 8 | Nader Francois Director | 2021-01-26 17:12:15 | 0 0 | 0 | Form 4 |
| 9 | Minkow Emily Chief Business Officer | 2021-01-26 17:13:06 | 0 0 | 0 | Form 4 |
| 10 | Kaplan Brett Chief Financial Officer | 2021-01-26 17:14:19 | 0 0 | 0 | Form 4 |
| 11 | Hefti Franz Chief Development Officer | 2021-01-26 17:15:10 | 0 0 | 0 | Form 4 |
| 12 | Dai Yong Chief Technology Officer | 2021-01-26 17:16:04 | 0 0 | 0 | Form 4 |
| 13 | Carson William H. Director | 2021-01-26 17:17:16 | 0 0 | 0 | Form 4 |
| 14 | Adams Timothy M Director | 2021-01-26 17:18:50 | 0 0 | 0 | Form 4 |
| 15 | Abeliovich Asa President & CEO | 2021-01-26 17:19:57 | 0 0 | 0 | Form 4 |
| 16 | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC Director 10% Owner | 2021-01-28 20:30:12 | 0 0 | 0 | Form 13D |